scholarly journals Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic

2021 ◽  
Vol 9 ◽  
Author(s):  
Giulia Baresi ◽  
Mauro Giacomelli ◽  
Daniele Moratto ◽  
Marco Chiarini ◽  
Immacolata Claudia Conforti ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Severe Acute Respiratory Syndrome ◽  
Cystic Fibrosis Patient ◽  
Inflammatory Cytokines ◽  
Inflammatory Markers ◽  
The Other ◽  
Infectious Episode ◽  
Before And After ◽  
Report Analysis

Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID-19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection.

scholarly journals A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Daniel Goldenberger ◽  
Vladimira Hinić ◽  
Spasenija Savic Prince ◽  
Michael Tamm ◽  
Anna-Maria Balestra ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Cystic Fibrosis Patient ◽  
Extraction Method

scholarly journals COVID-19-Associated Coagulopathy: A Case Report of Thrombosis despite Therapeutic Anticoagulation

2020 ◽  
Vol 2020 ◽  
pp. 1-4 ◽  
Author(s):  
Habiba Hussain ◽  
Matthew Sehring ◽  
Bhagat Singh Aulakh
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Case Report ◽  
Severe Acute Respiratory Syndrome ◽  
Hospital Stay ◽  
Inflammatory Markers ◽  
Morbidity And Mortality ◽  
Management Guidelines ◽  
Disease Prognosis ◽  
Therapeutic Anticoagulation

The Coronavirus disease (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has led to tremendous morbidity and mortality. Various inflammatory markers have been monitored and considered to be associated with disease prognosis. One of the major sources of comorbidity involved has been development of thrombosis alongside the infection. This prothrombotic phenomenon considered, COVID-19-associated coagulopathy (CAC), has been the center of discussion in dealing with this infection. There still remains ambiguity regarding management guidelines for thromboprophylaxis dosing and therapeutic anticoagulation. We present a case of severe SARS-CoV-2 infection complicated by thrombosis despite therapeutic anticoagulation contributing to prolonged intensive care unit and hospital stay.

scholarly journals Exceptional third-time single-lung transplantation in a cystic fibrosis patient with previous pneumonectomy: a case report

2020 ◽  
Vol 2 ◽  
pp. 10-10
Author(s):  
Françoise Le Pimpec-Barthes ◽  
Giuseppe Mangiameli ◽  
Ciprian Pricopi ◽  
Alex Arame ◽  
Anne Hernigou ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Lung Transplantation ◽  
Cystic Fibrosis Patient ◽  
Single Lung Transplantation

scholarly journals Shigella sonnei bacteraemia in a cystic fibrosis patient: case report and literature review

2020 ◽  
Vol 2 (2) ◽  
Author(s):  
Octavio Carretero-Vicario ◽  
Irene Taravillo ◽  
Laura Corbella ◽  
Mercedes Catalan ◽  
Cristina Garfia ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Literature Review ◽  
Cystic Fibrosis Patient ◽  
Shigella Sonnei ◽  
Patient Case

scholarly journals Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Vanitha Mariappan ◽  
Surendran Thavagnanam ◽  
Kumutha Malar Vellasamy ◽  
Cindy Ju Shuan Teh ◽  
Nadia Atiya ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Cystic Fibrosis Patient ◽  
First Case

scholarly journals Pseudomonas aeruginosacross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe

1989 ◽  
Vol 102 (2) ◽  
pp. 205-214 ◽  
Author(s):  
Christiane Wolz ◽  
Gerd Kiosz ◽  
John W. Ogle ◽  
Michael L. Vasil ◽  
Urs Schaad ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Antibiotic Therapy ◽  
Summer Camp ◽  
Dna Probe ◽  
The Other ◽  
Sibling Pairs ◽  
Long Period ◽  
Strain Change ◽  
Before And After ◽  
Different Strains

SUMMARYTo investigate cross-colonization with and persistence ofPseudomonas aeruginosain cystic fibrosis (CF). 181 isolates from 76 CF patients were typed using aP. aeruginosa-specific DNA probe. Whereas sibling pairs predominantly harboured genotypically identicalP. aeruginosastrains, all of the other patients harboured different strains. Seventy-nine per cent (22/31) of the infected CF patients harboured the same strains at the beginning and the end of a summer camp. A change of strains was seen in 10% (3/31) of the patients at the end of the camp. Forty-six per cent (6/13) of the patients who were apparently initially uninfected, acquiredP. aeruginosaby the end of the period. Genotyping proved that strain change or acquisition was due to cross-colonization in four of nine cases. Very littleP. aeruginosawas isolated from the inanimate environment. Persistence ofP. aeruginosaafter a temporary loss due to antibiotic therapy was seen in 12/16 paired patient strains before and after antibiotic therapy. Thus, suppression followed a flare-up seemed to occur in these patients rather than eradication and a new infection. When 35 patients were followed over a period of 6 months, 7 (20%) changed the strain in their sputum. Only one of 43 patients harboured two differentP. aeruginosastrains simultaneously over a long period.

scholarly journals Burkholderia pseudomalleiInfection in a Cystic Fibrosis Patient from the Caribbean: A Case Report

2008 ◽  
Vol 15 (5) ◽  
pp. 237-239 ◽  
Author(s):  
Dimas Mateos Corral ◽  
Allan L Coates ◽  
Yvonne CW Yau ◽  
Raymond Tellier ◽  
Mindy Glass ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Southeast Asia ◽  
Cystic Fibrosis Patient ◽  
North American ◽  
Burkholderia Pseudomallei ◽  
Northern Australia ◽  
The Caribbean ◽  
Endemic Areas

Burkholderia pseudomalleiis a pathogen identified with increasing frequency in the respiratory tracts of cystic fibrosis (CF) patients from endemic areas such as Southeast Asia and northern Australia. The following report describes the first known reported case in a CF patient from the Caribbean attending a North American CF clinic.

Cilia from a cystic fibrosis patient react to the ciliotoxicPseudomonas aeruginosaII lectin in a similar manner to normal control cilia – a case report

1997 ◽  
Vol 111 (8) ◽  
pp. 760-762 ◽  
Author(s):  
Elizabeth C. Adam ◽  
Dietlind U. Schumacher ◽  
Udo Schumacher
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Case Report ◽  
Cystic Fibrosis Patient ◽  
Normal Control ◽  
Nasal Polyp ◽  
Nasal Polyps ◽  
Beat Frequency ◽  
Ciliary Beat Frequency ◽  
Ciliary Beating

AbstractThe ciliary beat frequency measurements taken from a nasal polyp from a cystic fibrosis patient were similar to that of the control nasal polyps. The addition of a ciliotoxic lectin produced byPseudomonas aeruginosastopped the beating of the cilia as in the controls. This reaction could be blocked by the pre-incubation of the lectin with its inhibitor fucose. As in the control, the addition of fucose after the cilia had slowed resulted in a return to normal ciliary beating within 24 hours. This shows that the delta F508 CF mutation observed in this patient does not affect ciliary beating and suggests that treatment with fucose in the early stages of aPseudomonas aeruginosainfection could be advantageous for cystic fibrosis patients.

Sign in / Sign up

Export Citation Format

Share Document